Navigation Links
UL Announces RoHS II Services for Medical and Laboratory Equipment
Date:4/30/2013

NORTHBROOK, Ill., April 30, 2013 /PRNewswire/ -- UL (Underwriters Laboratories), a world leader in advancing safety, announced today the launch of a new program supporting medical devices and laboratory equipment manufacturers in their RoHS II Directive (2011/65/EU) compliance efforts.

Many manufacturers of medical and laboratory equipment previously excluded from the Scope of the original RoHS Directive are now finding that their devices are within Scope of the recast RoHS II Directive. Manufactures placing these devices in Europe must be in compliance with the new Directive by July 22, 2014.  Due diligence on the part of these manufacturers is required to ensure that their Declaration of Conformity and Technical File meets the applicable requirements.  UL offers these manufacturers support in their due diligence efforts, including a gap analysis of their process, compilation of documents supporting the technical file, analytical testing and more.

"In order to legally market devices in the EU, medical device and laboratory equipment manufacturers must comply with many regulations, including the new RoHS II Directive," said Anil Patel, vice president and general manager of UL health sciences. "This program gives manufacturers needed support in helping to ensure that their products are in full compliance with not only safety, but environmental regulations as well - an area which is receiving increasing focus world-wide."

Under the RoHS II Directive, end-product manufacturers will work with their suppliers to manage compliance and compile technical documentation as evidence of compliance. Because the approach required by the legislation is of a general nature, integrating RoHS assessment services with other regulatory assessments can help manufacturers streamline, and thereby improve, business processes.

"We view the RoHS II Directive as a positive move in protecting our environment, and right in line with our mission at UL to support the production and use of products which are physically and environmentally safe," said Mark Leimbeck , Program Manager for UL's Health Sciences Industry. "This initiative provides us an opportunity to actively engage the industry, support streamlined efforts to ensure regulatory compliance, and provide a safer and cleaner environment for our children and ourselves."

About UL

UL is a premier global independent safety science company with more than 118 years of history. Employing more than 10,000 professionals in over 100 countries, UL has five distinct business units – Product Safety, Environment, Life & Health, Knowledge Services, and Verification Services – to meet the expanding needs of our customers and to deliver on our public safety mission.  Additional information about UL may be found at UL.com.

Contact: Tara Kambeitz
Global Marketing Manager
UL
T: +1 360 263 6987
E: Tara.L.Kambeitz@ul.com


'/>"/>
SOURCE UL
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
2. NextBio Announces Translational Medicine Partnership with Sanofi
3. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
4. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
5. Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
6. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
7. FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
8. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
9. ConvaTec Announces 2012 Year-End Earnings Call
10. IRIDEX Announces First Quarter 2013 Conference Call and Release Date
11. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... England och PITTSBURGH ... Erbjudandet lämnas inte, och detta pressmeddelande ... indirekt, i eller till, och inga anmälningssedlar ... av aktieägare i, något land där Erbjudandet, ... accept av Erbjudandet skulle strida mot tillämpliga ...
(Date:2/10/2016)... February 10, 2016 A new report from business intelligence ... states that the Alzheimer,s disease market will more than double from just under ... Compound Annual Growth Rate (CAGR) of 11%. Canada , ... , Spain , the UK, and Japan ... forecast period. --> Canada , France ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , ... in the North Metro Denver area. The new dental practice focuses on comfort where ... in the most relaxing environment. , While some dental visits can create anxiety for ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology ... quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after ... the investment community following the release at 4:30 PM ET. Investors interested in participating ...
Breaking Medicine News(10 mins):